Artificially sweetened beverage intake and risk of liver-related adverse events in individuals with MASLD: A prospective UK Biobank cohort study
Ning Xu, Jiaxi Lin, Lu Liu, Shiqi Zhu et autres
Abstract Purpose Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and liver-related morbidity worldwide. Although dietary factors may influence MASLD progression, the long-term liver-specific implications of artificially sweetened beverage (ASB) intake remain unclear. We aimed to …
cn, hk (code pays fourni par la source)
0 citations
medRxiv